ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Jianpi-Huayu Formula Inhibits Development of Hepatocellular Carcinoma by Regulating Expression of miR-602, Which Targets the RASSF1A Gene

Huang, Yajing; Zhou, Cheng; Wen, Huihong; Chen, Yongxu; Xie, Yingjie; Lan, Xiaohe; Lin, Juze; Huang, Xuhui; Mo, Yousheng; Yang, Cong; Wang, Qi; Wang, Changjun*广东省人民医院; 广州中医药大学; 1
INTEGRATIVE CANCER THERAPIES2020-2DOI: 10.1177/1534735419900804
4被引10阅读
引用收藏
分享

摘要

The traditional Chinese medicine formula Jianpi-Huayu (JPHY) has been reported to be effective in the treatment of hepatocellular carcinoma (HCC). However, its underlying mechanism remains unclear. In this article, we employed an orthotopic transplantation model in nude mice to explore whether JPHY could inhibit the development of HCC by regulating miR-602, which targets the Ras association domain-containing protein 1A (RASSF1A) pathway. HCC SMMC-7721 cells were treated with JPHY to test whether the RASSF1A gene as mediated by miR-602 affected the proliferation and apoptosis of tumor cells. We subsequently detected miR-602, RASSF1A, and tumor cell apoptosis-related markers in cells and liver tumor tissues. We observed that mice treated with JPHY had smaller tumors and higher survival rates than untreated ones. Similarly, JPHY-treated SMMC-7721 cells exhibited alterations in morphology and higher cytotoxicity compared with the control group. Furthermore, we found that JPHY decreased overexpression of miR-602 and increased protein expression levels of the RASS1A gene, which in turn altered protein expression levels of tumor cell apoptosis-related genes in the cells and liver tumor tissues of drug-treated mice. These results indicated that JPHY could potentially be used to treat HCC by targeting miR-602, which targets the RASSF1A gene, which in turn plays a major role in HCC pathogenesis.

学科与关键词

关键词
Jianpi-Huayu formulamiR-602RASSF1Ahepatocellular carcinomaSMMC-7721apoptosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
INTEGRATIVE CANCER THERAPIES
发表日期
2020-02
卷期
第 19 卷
页码
1534735419900804
DOI
10.1177/1534735419900804
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81774261]; administration of Traditional Chinese Medicine of Guangzhou, China [20171001]

作者

  • H

    Huang, Yajing (第一作者)

    guangzhou univ chinese med · guangdong prov peoples hosp

  • Z

    Zhou, Cheng

    guangdong prov peoples hosp

查看全部 12 位作者收起作者
  • W

    Wen, Huihong

  • C

    Chen, Yongxu

    1

  • X

    Xie, Yingjie

    guangdong prov peoples hosp

  • L

    Lan, Xiaohe

    guangdong prov peoples hosp

  • L

    Lin, Juze

    guangdong prov peoples hosp

  • H

    Huang, Xuhui

    guangdong prov peoples hosp

  • M

    Mo, Yousheng

    guangzhou univ chinese med

  • Y

    Yang, Cong

    guangzhou univ chinese med

  • W

    Wang, Qi

    guangzhou univ chinese med

  • W

    Wang, Changjun (通讯)

    guangdong prov peoples hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417